CN115315264A - 人参皂苷组合物 - Google Patents
人参皂苷组合物 Download PDFInfo
- Publication number
- CN115315264A CN115315264A CN202180022225.5A CN202180022225A CN115315264A CN 115315264 A CN115315264 A CN 115315264A CN 202180022225 A CN202180022225 A CN 202180022225A CN 115315264 A CN115315264 A CN 115315264A
- Authority
- CN
- China
- Prior art keywords
- ginsenosides
- weight
- composition
- gut microbiota
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004121.6A GB202004121D0 (en) | 2020-03-20 | 2020-03-20 | Improved compositions |
| GB2004121.6 | 2020-03-20 | ||
| GB2005288.2 | 2020-04-09 | ||
| GBGB2005288.2A GB202005288D0 (en) | 2020-04-09 | 2020-04-09 | Improved compositions |
| PCT/EP2021/056803 WO2021185897A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115315264A true CN115315264A (zh) | 2022-11-08 |
Family
ID=75108332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180022225.5A Pending CN115315264A (zh) | 2020-03-20 | 2021-03-17 | 人参皂苷组合物 |
| CN202180022249.0A Pending CN115315266A (zh) | 2020-03-20 | 2021-03-17 | 人参皂苷组合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180022249.0A Pending CN115315266A (zh) | 2020-03-20 | 2021-03-17 | 人参皂苷组合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230124503A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4121061A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7808042B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN115315264A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021238639B2 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112022015826A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3174699A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021185897A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117224553A (zh) * | 2023-11-02 | 2023-12-15 | 浙江大学 | 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用 |
| CN117752706A (zh) * | 2023-12-20 | 2024-03-26 | 浙江天皇药业有限公司 | 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230124503A1 (en) * | 2020-03-20 | 2023-04-20 | Givaudan Sa | Ginsenoside compositions |
| JP2023161983A (ja) * | 2022-04-26 | 2023-11-08 | 石川県公立大学法人 | サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物 |
| WO2025261873A1 (en) | 2024-06-20 | 2025-12-26 | Givaudan Sa | Improvements in or relating to compounds |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100278944A1 (en) * | 2009-05-04 | 2010-11-04 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US20150306119A1 (en) * | 2009-05-04 | 2015-10-29 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US20160339070A1 (en) * | 2013-11-04 | 2016-11-24 | Wen Luan Wendy Hsiao | Use of herbal saponins to regulate gut microflora |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040202731A1 (en) * | 2003-04-08 | 2004-10-14 | Gow Robert T. | Rosmarinic acid composition |
| KR102200012B1 (ko) * | 2013-04-02 | 2021-01-08 | (주)아모레퍼시픽 | 인삼열매 추출물을 포함하는 뇌 활성화 조성물 |
| BR112020000963A2 (pt) | 2017-07-18 | 2020-07-14 | Senescence Life Sciences Pte. Ltd. | composições e métodos para o tratamento e prevenção de declínio cognitivo e conservação da função neuronal |
| CN110613802A (zh) * | 2018-06-20 | 2019-12-27 | 珠海岐微生物科技有限公司 | 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途 |
| US20230124503A1 (en) | 2020-03-20 | 2023-04-20 | Givaudan Sa | Ginsenoside compositions |
-
2021
- 2021-03-17 US US17/905,849 patent/US20230124503A1/en active Pending
- 2021-03-17 WO PCT/EP2021/056803 patent/WO2021185897A1/en not_active Ceased
- 2021-03-17 EP EP21712999.8A patent/EP4121061A1/en active Pending
- 2021-03-17 BR BR112022015826A patent/BR112022015826A2/pt unknown
- 2021-03-17 CA CA3174699A patent/CA3174699A1/en active Pending
- 2021-03-17 AU AU2021238639A patent/AU2021238639B2/en active Active
- 2021-03-17 BR BR112022016241A patent/BR112022016241A2/pt unknown
- 2021-03-17 CN CN202180022225.5A patent/CN115315264A/zh active Pending
- 2021-03-17 WO PCT/EP2021/056788 patent/WO2021185890A1/en not_active Ceased
- 2021-03-17 CA CA3174698A patent/CA3174698A1/en active Pending
- 2021-03-17 CN CN202180022249.0A patent/CN115315266A/zh active Pending
- 2021-03-17 US US17/905,868 patent/US20230129389A1/en active Pending
- 2021-03-17 EP EP21713906.2A patent/EP4121076A1/en active Pending
- 2021-03-17 JP JP2022555990A patent/JP7808042B2/ja active Active
- 2021-03-17 AU AU2021238643A patent/AU2021238643A1/en active Pending
- 2021-03-17 JP JP2022556000A patent/JP7850670B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100278944A1 (en) * | 2009-05-04 | 2010-11-04 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US20150306119A1 (en) * | 2009-05-04 | 2015-10-29 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US20160339070A1 (en) * | 2013-11-04 | 2016-11-24 | Wen Luan Wendy Hsiao | Use of herbal saponins to regulate gut microflora |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
Non-Patent Citations (4)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117224553A (zh) * | 2023-11-02 | 2023-12-15 | 浙江大学 | 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用 |
| CN117752706A (zh) * | 2023-12-20 | 2024-03-26 | 浙江天皇药业有限公司 | 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021238639B2 (en) | 2026-06-25 |
| EP4121061A1 (en) | 2023-01-25 |
| WO2021185897A1 (en) | 2021-09-23 |
| US20230129389A1 (en) | 2023-04-27 |
| AU2021238643A1 (en) | 2022-10-20 |
| WO2021185890A1 (en) | 2021-09-23 |
| US20230124503A1 (en) | 2023-04-20 |
| BR112022015826A2 (pt) | 2022-10-04 |
| CA3174699A1 (en) | 2021-09-23 |
| CA3174698A1 (en) | 2021-09-23 |
| EP4121076A1 (en) | 2023-01-25 |
| BR112022016241A2 (pt) | 2022-10-11 |
| JP7850670B2 (ja) | 2026-04-23 |
| JP2023518064A (ja) | 2023-04-27 |
| JP2023519189A (ja) | 2023-05-10 |
| JP7808042B2 (ja) | 2026-01-28 |
| CN115315266A (zh) | 2022-11-08 |
| AU2021238639A1 (en) | 2022-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7808042B2 (ja) | ギンセノシド組成物 | |
| Tian et al. | Digestive characteristics of Hericium erinaceus polysaccharides and their positive effects on fecal microbiota of male and female volunteers during in vitro fermentation | |
| JP5204771B2 (ja) | Gaba作動性ニューロン賦活剤 | |
| Liu et al. | Microbiome and metabolome integrally reveal the anti-depression effects of Cistanche deserticola polysaccharides from the perspective of gut homeostasis | |
| CN110636760B (zh) | 肠道健康促进组合物 | |
| WO2022127934A1 (zh) | 人参皂苷在改善肠道菌群结构和/或肠屏障功能的应用 | |
| Martirosyan et al. | The bioactive compounds of probiotic foods/supplements and their application in managing mental disorders | |
| Campaniello et al. | A narrative review on the use of probiotics in several diseases. Evidence and perspectives | |
| Luo et al. | Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice | |
| Kim et al. | A prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in rats | |
| US20210121505A1 (en) | Compositions and methods for treating inflammatory bowel diseases | |
| JPWO2008155998A1 (ja) | 抗不安抗うつ剤 | |
| JP2020533008A (ja) | Megamonas funiformis及びその適用 | |
| Pan et al. | Antiobesity effect of Lactiplantibacillus plantarum fermented barley extracts via the interactions with gut microbiota of the obese adult humans | |
| JP7514926B2 (ja) | 個別化腸内細菌叢の多様性を整える機能を有する組成物及び使用 | |
| WO2020200212A1 (zh) | 用于预防和治疗代谢类疾病的土壤制剂及其制备方法与应用 | |
| CN103932000B (zh) | 一种复合双歧因子的灵芝孢子粉咀嚼片及其制备工艺 | |
| Li et al. | Hemp seed oil ameliorates CFA-induced rheumatoid arthritis in rats by improving metabolic abnormalities and gut microflora | |
| TWI810645B (zh) | 乳桿菌組合物及其改善抗生素造成之焦慮症的用途 | |
| CN112956689A (zh) | 一种改善便秘的奇异果益生菌的组合物及其应用 | |
| Chi | Study on biofate and antidepressive mechanism of fructooligosaccharides from Morinda officinalis | |
| JP7500897B2 (ja) | 腸内菌叢改善用組成物 | |
| CN121081559A (zh) | 西红花、小蓟、桔红、黄芥子、黑芝麻和青果在制备益生元模拟物的药物或者制剂中的应用 | |
| WO2026078116A1 (en) | Substances for use as a prebiotic or as a medicine | |
| CN116270607A (zh) | 一种具有调节肠道菌群作用的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |